Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business

Conference call to be held today, 11November 2019, 11 a.m. CET/10 a.m. GMT   Heidelberg, Germany and Cambridge - Expedeon AG (Frankfurt: EXNN; ISIN: DE000A2YN801; Prime Standard) announces the signing of an agreement with Abcam plc (London Stock Exchange: ABC; ISIN: GB00B6774699; AIM MTF), Cambridge, UK, to sell its proteomics and immunology business activities for a [...]

ARTeSYN Biosolutions Expands Manufacturing Capability in Waterford

Manufacturer of single-use components & systems within the biotech industry to create 50 new jobs and invest €1M in manufacturing & clean room facilities Waterford – Minister for Training, Skills, Innovation, Research and Development John Halligan TD announced today that ARTeSYN Biosolutions, the manufacturer of single-use solutions for biopharma processing, is to significantly expand its Waterford operations by [...]

Horizon Discovery divests animal models business to Envigo

Animal model operations to be transferred to Envigo ownership Divestment in line with Horizon’s corporate strategy to focus on its core markets Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business Horizon and Envigo to collaborate on providing CRISPR screening services Cambridge, UK, 08 November 2019: Horizon [...]

Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Portfolio

BrickBio’s technology enables efficient placement of unnatural amino acids into recombinant antibodies at specific sites Together, the organizations will industrialize the technology to serve both the research and diagnostic markets CAMBRIDGE, UK and BOSTON, MA, USA -- Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce a strategic partnership [...]

Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors

Appointment follows resignation of Director Dr. Charles Ryan STONY BROOK, N.Y. –  Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity, traceability solutions and nucleic acid-based biotherapeutic research, today announced the appointment of Scott L. Anchin to its Board of Directors following the resignation [...]

Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery

First-in-class software platform digitalizes Twist Biopharma’s innovative antibody lead identification and optimization SAN FRANCISCO--Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Twist Biopharma, a division of Twist Bioscience (NASDAQ: TWST), has adopted Genedata Biologics® to support their R&D innovation for biologics drug discovery services. In addition, Twist will use the [...]

Million Microbiome of Humans Project (MMHP) is launched, aiming to build the world’s largest human microbiome database

SHENZHEN, China -- The "Million Microbiome of Humans Project" (MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14). Scientistsfrom China, Sweden, Denmark, France, Latvia and other countries will cooperate in microbial metagenomic research, aiming to sequence and analyze one million microbial samples from intestines, mouth, skin, reproductive tract and other organs in the next three to five years to [...]

prismCDX Implements Ultivue’s UltiMapper™ Platform for Standardized, Comprehensive Cancer Tissue Phenotypic Characterization

SEOUL, South Korea--prismCDX, a highly specialized contract research organization announced today the selection and adoption of the UltiMapper platform to broaden its offering of translational biomedical research services. The addition of Ultivue’s highly standardized multiplex tissue marker assays enables the identification of critical cellular phenotypes and tissue marker signatures in support of translational and clinical [...]

ATCC Celebrates Building Expansion with Groundbreaking Ceremony

MANASSAS, Va. -- ATCC launched its second headquarters expansion with a groundbreaking ceremony that celebrates its continued commitment to innovative science and to the global scientific enterprise and to its local community in Prince William County. The ceremony occurred 21 years – nearly to the day – after ATCC broke ground on its headquarters in November 1998. Expected [...]

Targos and Ultivue partner to incorporate highly standardized UltiMapper™ tissue multiplex phenotypic assays in support of clinical research services

Kassel, Germany and Cambridge, MA – Targos Molecular Pathology GmbH, a market leader in clinical biomarker services announced today a technology partnership with Ultivue, the innovation leader in multiplex tissue biomarker assays, to offer the biopharmaceutical industry new capabilities to improve the characterization of cancer patients’ samples selected for clinical research programs. UltiMapper multiplex immuno-histochemistry [...]

Access IBO on Knowledge Center